Latest Revenue Growth News

Tamawood Limited has posted an 18.5% increase in revenue for the year ended June 2025, alongside a modest rise in net profit, while maintaining a strong balance sheet and reinstating its dividend reinvestment plan.

RooLife Group has secured a two-year supply agreement with Eternal Asia, granting access to over one million retail outlets across China and potential annual orders worth up to AUD 110 million.

Lindian Resources has locked in a US$20 million funding facility and a 15-year offtake agreement with Iluka Resources, cementing a strategic partnership that advances the Kangankunde Rare Earths Project and links supply to Australia’s Eneabba refinery.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.

AML3D has appointed German firm DMFG Solutions as a second European distributor, complementing its recent UK partnership and supporting a AU$5 million investment in a new technology centre.

REA Group Ltd reported a robust FY25 with 15% revenue growth to $1.673 billion and a 23% rise in net profit, driven by strong Australian market performance and strategic AI investments. The company also advanced its India operations, focusing on Housing.com amid PropTiger divestment plans.

REA Group has reported a robust FY25 with strong revenue and profit growth, underpinned by solid Australian market performance and strategic moves in India. The company also announced a leadership transition amid optimistic FY26 guidance.

REA Group Ltd has reported robust FY25 results with a 15% increase in revenue and a 23% rise in core net profit, alongside a 31% lift in dividends. The company also announced the retirement of CEO Owen Wilson after a decade at the helm.

Trajan Group Holdings has reported record FY25 revenue of $166.5 million, exceeding guidance despite operational headwinds. However, EBITDA fell slightly short of forecasts, reflecting challenges in supply chains and market shifts.

Telix Pharmaceuticals has recast its historical financials from AUD to USD to better reflect its US-centric revenue streams and reports increased operating expenditure tied to recent acquisitions and growth initiatives.

Reckon Limited delivered a robust half-year performance in HY25, driven by strong cloud revenue growth and a key acquisition that expanded its SME client base. The company also declared a fully franked dividend, underscoring confidence in its ongoing strategy.

Reckon Limited has reported a robust first half of 2025, marked by significant revenue and profit growth fueled by organic expansion and the acquisition of Cashflow Manager. The company’s cloud-based Reckon One product and US-focused Legal Group continue to drive momentum.